| Term 
 
        |   Role of Opioid Analgesics |  | Definition 
 
        |   Agent of choice for moderate to severe pain (especially visceral)   Used for limited perioid of time in most patients |  | 
        |  | 
        
        | Term 
 
        |   Patient Controlled Analgesics |  | Definition 
 
        |   Keeps pain under control Gets the patient involved Proper patient selection is critical Ideal for acute, sharp, post-op pain Patients activate pump when they feel a little pain Y-tubing site close to injection site |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   Programming Errors Pump Failure PCA by proxy => family member thinking pt is in pain |  | 
        |  | 
        
        | Term 
 
        |   Patient Controlled Analgesia   Adult Dosing   Intermittent Dose, Lockout Interval, Hour Limit, 4 Hour Limit, Basal Rate |  | Definition 
 
        |   Adult:  25-50 mcg/kg or 2-4 mg morphine   Intermittent Dose:  1 mg Lockout Interval:  5-10 minutes Hour Limit:  5 mg 4 Hour Limit:  15-20 mg Basal Rate:  2 mg/hr |  | 
        |  | 
        
        | Term 
 
        |   Patient Controlled Analgesia Potential Benefits of Fentanyl (2) |  | Definition 
 
        |   Short duration may aid tiration Less NV, urinary retention, and sedation |  | 
        |  | 
        
        | Term 
 
        |   Patients who will benefit from basal rate (4) |  | Definition 
 
        |   Patient who undergo major surgery Patient who hits limit every hour Patient with high dosing requirement during first 24-48 hours Patient who wake up frequently at night with pain   |  | 
        |  | 
        
        | Term 
 
        |   Monitoring Patients PCA (5) |  | Definition 
 
        |   Every 4 hours until stable Basal Rate Number of Attempts Number of Injections Ask patient how they feel:  HR, BP, Pain Scale |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   Cut or stop basal rate when patient stops attempts If patient waits too long between injections, re-bolus If patient needs more drug:  increase intermittent dose by 50% increasing 1 and 4 hr limit If this increase dose not work ,increase dose by 50% of the first increase Always reassess if patient needs to be re-bolused!!! |  | 
        |  | 
        
        | Term 
 
        |   Epidural/Inthrathecal Analgesia |  | Definition 
 
        |   Usually intentded for short-term use Useful post-op and some OB patients when epidural catheter is already in place Useful when pts can NO longer tolerate SE associated with Oral or IV Useful in terminal patients Not achieving pain relief by conventional means Used in some pain patients when other treatment proves unsuccessful |  | 
        |  | 
        
        | Term 
 
        |   Epidural/Intrathecal Analgesia Monitoring SEs (2) |  | Definition 
 
        | Patients must be monitored and stabalized over 48 hour period   Any respiratory depression may be delayed   Itching and Urinary Retention more Common   Risk of infection |  | 
        |  | 
        
        | Term 
 
        |   Epidural/Intrathecal Analgesia Dosing is Emperic for (3) |  | Definition 
 
        |   Morphine Hydromorphone Fentanyl   USE ONLY PRESERVATIVE FREE PRODUCTS AND DILUENTS |  | 
        |  | 
        
        | Term 
 
        |   DepoDur Morphine Extended-Release Liposome Injection |  | Definition 
 
        |   Provides analgesia up to 48 hours Administered into lumbar spaces prior to surgery Eliminates need for catheter and pumo Stored in refrigerator must be used with 4 hours after withdrawing from vial   |  | 
        |  | 
        
        | Term 
 
        |   Clonidine-Duraclon Ziconotide-Prialt MOAs |  | Definition 
 
        | Blocks Alpha-2 Receptor (Best for Neuropathic Pain)   Synthetic peptide from sea snail venom indicated for IT injection to manage severe chronic pain in patients who do NOT respond to other therapies   |  | 
        |  | 
        
        | Term 
 
        |   Managemtn of Chronic Pain Non-visceral/Non-somatic   Mild to Moderate Pain (4) Step 1 Options (3) |  | Definition 
 
        |   Arthritis Neuropathies Fibromyalgia Low back pain   APAP NSAIDs Tramadol with Routine Dosing   |  | 
        |  | 
        
        | Term 
 
        |   Management of Chronic Pain Non-Visceral/Non-Somatic   Step 2 Options (2) |  | Definition 
 
        |   Use SR forms of Step 1 drugs Long Acting NSAIDs ER forms of Tramadol   Ultram ER titrate over 5 days Ryzolt tirate over 5 days |  | 
        |  | 
        
        | Term 
 
        |   Management of Chronic Pain Non-Visceral/Non-Somatic Step 3 Options (3) |  | Definition 
 
        | Continue Step 1 and 2 drugs   Avoid chronic use of opioids if possible Conside use of buprenorphine patch |  | 
        |  | 
        
        | Term 
 
        |   Management of Chronic Pain Non-Visceral/Non-Somatic   Lower Back Pain Treatment Guidelines (5) |  | Definition 
 
        |   NSAIDs or APAP Heat massage, activity, rehabilitation, acupuncture, spinal manipulation   Injectable corticosteroids if there is evidence of inflammation Muscle Relaxants for acute use only TCS, gabapentin, topirimate (mixed results) Opioids should be reserved for pts with severe pain NOT relieved by other agents (less effect with chronic use) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   Often the result of loss of inhibitory activities of the descending pathway on pain transmission |  | 
        |  | 
        
        | Term 
 
        |   Conditions associated with Neuropathic Pain (10) |  | Definition 
 
        | Diabetic Neuropathies Lower Back Pain Trigeminal Neuralgia HIV Sensory Neuropathy Tumor Infiltration Post-Herpetic Neuralgia Cancer Pain Some Headaches Spinal Cord Injury Phantom Limb Pain |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   Severe Pain Extremely sensitive to tough or temperature Feeling of clothing against skin is painful Condition can last for months   |  | 
        |  | 
        
        | Term 
 
        |   Treatment of Neuropathic Pain General Principles (5) |  | Definition 
 
        |   Initiate one drug at a time Use drugs with the lowest SE profile Start at low dose, slowly increase dose evaluating benefit vs. SE for tx failure, try alternative agents within same class Education:  full benefit may take days to weeks with full pain relief NOT expected |  | 
        |  | 
        
        | Term 
 
        |   Treatment of Neuropathic Pain Antidepressants MOA Effect Medications (4) |  | Definition 
 
        |   Agents with activity against NE and serotonin most effective Analgesic effect takes at least 1 week   Amitriptyline (Elavil) Nortriptyline (Pamelor) Desipramine (Norpramin) start at 10-25 mg po hs (max 100-150 mg) Venlafaxine (Effexor XR) 150-225 mg/day |  | 
        |  | 
        
        | Term 
 
        |   Treatment of Neuropathic Pain Duloxentine (Cymbalta) |  | Definition 
 
        |   30-60mg/day Not superior to other antidepressants Avoid in pts with liver disease Urinary hesitancy reported |  | 
        |  | 
        
        | Term 
 
        |   Treatment of Neuropathic Pain MOA Medications (6) |  | Definition 
 
        |   Inhibit glutamate activity Enhance GABA activity Carbamazepine Phenytoin Gabapentin Pregabalin Lamotrigine Topiramate |  | 
        |  | 
        
        | Term 
 
        |   Gabapentin Dosing   Gabapentin Extend-Release (Gralise) |  | Definition 
 
        |   900-1800 mg/day max:  3600 mg/day Start at 100 mg TID Taper when d/c   Marketed for post-herpetic neuralgia Taken once daily with evening meal Dose is titrated over 2 weeks to max of 1800 mg |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   Start at 75 mg BID Titrate to 150 mg BID No benefit at doses > 300 mg/day SE dose related d/c gradually to avoid withdrawl symptoms |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   Depletes stores of Substance P which inhibits pain transmission and inflammation   For pain from arthritis and neuropathies Apply 3-4 times daily A burning sensation may occur   Wash hands thoroughly with soap and water Inital relief is usually noted within 1-2 weeks Daily application is necessary to sustain pain relief |  | 
        |  | 
        
        | Term 
 
        |   Capasaicin 8% Patch (Qutenza) |  | Definition 
 
        |   Only indicated for PHN Apply for 1 hours q 3 months Design for application by HCP Use only NITRILE GLOVES Causes slight elevation in BP |  | 
        |  | 
        
        | Term 
 
        |   Lidocaine Patches 5% (Lidoderm) |  | Definition 
 
        |   Local Anesthetic No more than 3 (4) patches at a time Patches can be cut to fit affected area on for 12 hours, then off for 12 hours Apply on intact skin   |  | 
        |  | 
        
        | Term 
 
        |   Treatment of Neuropathic Pain Other Therapies (6) |  | Definition 
 
        |   Muscle relaxants/Antispasmotic => Tizandiine, Baclofen Lidocaine injections/Alcohol injections Clonidine (topical patches) Ketamine Injection or 5% gel (NMDA receptor antagonist) Botox injections (paralyzes nerves and muscles) |  | 
        |  | 
        
        | Term 
 
        |   Fibromyalgia Characterized by (2) Statistics Causes Sx (4) |  | Definition 
 
        |   Generalized muscle pain, fatigue   Imbalance of serotonin and NE are thought to be involved   Achiness ALL over Inability to sleep Stiffiness on wakening Tiredness during the day |  | 
        |  | 
        
        | Term 
 
        |   Fibromyalgia Criteria Classification (4) |  | Definition 
 
        |   Pain left/right sdie Pain above/below waist Pain for > 3 months Palpable pain at 11 of 18 indentified tender point sites |  | 
        |  | 
        
        | Term 
 
        |   Fibromyalgia Therapies with supporting evidence for use (6) |  | Definition 
 
        |   Amitriptyline Cyclobenzaprine Duloxetine Venlafaxine Tramadol Pregabalin |  | 
        |  | 
        
        | Term 
 
        |   Treatment of Fibromyalgia Milnacipran (Savella) |  | Definition 
 
        |   SNRI Only indicated for fibromyalgia 50-100 mg BID Nausea is common Monitor BP and HR   |  | 
        |  | 
        
        | Term 
 
        |   Fibromyalgia Non-pharmacological Treatment Options (3) |  | Definition 
 
        |   Exercise and muscle strengthening Cognitive behavioral therapy Patient education |  | 
        |  |